Login / Signup
Harsh P Nijhawan
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 5
Top Topics
Oxide Nanoparticles
Small Cell Lung Cancer
Epidermal Growth Factor Receptor
Drug Release
Top Venues
Therapeutic delivery
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Harsh P Nijhawan
,
Bala Prabhakar
,
Khushwant S Yadav
Central composite design augmented quality-by-design-based systematic formulation of erlotinib hydrochloride-loaded chitosan-poly (lactic-co-glycolic acid) nanoparticles.
Therapeutic delivery
15 (6) (2024)
Harsh P Nijhawan
,
Bala Prabhakar
,
Khushwant S Yadav
Central composite design augmented quality-by-design-based systematic formulation of erlotinib hydrochloride-loaded chitosan-poly (lactic-co-glycolic acid) nanoparticles.
Therapeutic delivery
15 (6) (2024)
Harsh P Nijhawan
,
Bala Prabhakar
,
Khushwant S Yadav
Central composite design augmented quality-by-design-based systematic formulation of erlotinib hydrochloride-loaded chitosan-poly (lactic-co-glycolic acid) nanoparticles.
Therapeutic delivery
(2024)
Harsh P Nijhawan
,
Bala Prabhakar
,
Khushwant S Yadav
Central composite design augmented quality-by-design-based systematic formulation of erlotinib hydrochloride-loaded chitosan-poly (lactic-co-glycolic acid) nanoparticles.
Therapeutic delivery
(2024)
Harsh P Nijhawan
,
Bala Prabhakar
,
Khushwant S Yadav
Central composite design augmented quality-by-design-based systematic formulation of erlotinib hydrochloride-loaded chitosan-poly (lactic-co-glycolic acid) nanoparticles.
Therapeutic delivery
15 (6) (2024)